Professor in Department of Chemistry, Iowa State University. Over 25 years of experience with over 80 publications in various fields of mass spectrometry including fundamentals, SIMS, ion mobility instrumentation, and proteomics. Current research interests include MALDI based mass spectrometry imaging of plant metabolites and forensic applications as well as analytical biomass pyrolysis especially with high-resolution mass spectrometry and dopant assisted atmospheric pressure ionization.
My work focuses on analytical chemistry with the development of methods for the analysis of organic micropollutants. I am also interested in passive sampling techniques to characterise the exposure of aquatic organisms (microalgae, biofilms).
In addition, I am carrying out analytical developments in the field of lipidomics to propose biomarkers of toxic effects in aquatic plants and marine or freshwater fish.
Senior Researcher at the National Institute of Chemical Physics and Biophysics, Tallinn, Estonia. Research interests and experience include ecotoxicology, environmental effects of engineered nanomaterials, fate and transport of contaminants of emerging concern, and microbiology.
Dr. Bernd Neumann is a German scientist in the field of microbiology. He has a Bachelor´s (B.Sc.) and Master´s (M.Sc.) degree in Human Biology from the University of Greifswald, Division Physiological Proteomics and Bioinformatics at the Institute for Microbiology (supervisor Katharina Riedel). He holds a PhD (Dr.rer.nat.) in Biology from the Technical University of Braunschweig. For his PhD and as PostDoc he worked at the Robert Koch Institute, Division of nosocomial pathogens and antibiotic resistances at the Department of infectious diseases.
Currently he is working as scientist at the Nuremberg General Hospital, Institute for hospital hygiene, medical microbiology and infectious diseases, that also is a university institute of the Paracelsus Medical University. He is working on antimicrobial resistant bacteria (ESKAPE-group) and resistance-mediating mobile genetic elements in the healthcare environment, mainly using molecular approaches as next-generation sequencing.
Scientist in Public Health at the Laboratory of Functional Genomics and Bioinformatics at the Oswaldo Cruz Institute (IOC, Fiocruz), Rio de Janeiro, Brazil. Scientific coordinator of the Institutional Bioinformatics Platform. CNPq Level 2 Research Productivity Scholar (Genetics). Permanent professor at the Graduate program on Systems and Computational Biology IOC, Fiocruz. Graduated in Biological Sciences - Genetics major - from the Federal University of Rio de Janeiro (2006), with a Master's degree in Cell and Molecular Biology from the IOC (2008) and PhD in Biophysics from UFRJ (2012). Through high performance technologies for DNA sequencing and computational data analysis, I investigate the effects of pollution on fauna, using fish as model organisms, and their responses and genetic adaptations to pollutants, especially those involved in the xenobiotic biotransformation system.
Team Leader, Molecular Surveillance, Biosecurity Group, Cawthron Institute, New Zealand.
Associate Professor, Institute of Marine Science, University of Auckland, New Zealand.
My research at the Cawthron Institute is highly applied and consist of developing multi-trophic molecular tools for environmental monitoring of marine industries (e.g. aquaculture farms, marine biosecurity in ports and marinas, and deep-sea exploration).
At the University of Auckland, I combine 'real-world' and 'blue-sky' research applications, including; i) investigating functional underpinnings of Symbiodiniaceae in coral reef ecosystems, ii) characterizing microbiomes in aquaculture and natural settings, iii) measuring eDNA and eRNA decay rates in marine invertebrates and vertebrates, iv) studying preferential settlement of marine invasive species associated with marine plastic debris, and v) exploring the diversity and dynamics of open-ocean plankton communities in the Pacific and beyond.
Lecturer in Cancer Informatics at Imperial College London and Fellow at Health Data Research (HDR) UK. Fellow of the Higher Education Academy (FHEA) and Member of the Royal Society of Chemistry (MRSC).
Dr Mirela Sedic (born Bauman) is Principal Scientist at the Institute for Anthropological Research Zagreb. She has authored over 50 scientific publications in peer-reviewed journals including high-impact journals such as BBA Molecular Basis of Disease, Molecular Cancer, The Journal of Pathology, Molecular Cancer Therapeutics, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Cancer Treatment Reviews.
She was the co-PI of international collaborative project with Functional Genomics Center Zurich in Switzerland (PRIME-XS-0000184 Proteomic profiling of retinal proteins from rat model of age-related macular degeneration 2012-2014) and the PI of the University of Rijeka grant “Screening and biological evaluation of acid ceramidase and sphingosine kinase inhibitors as a new class of anti-tumour agents” (2014 – 2017). She is currently the PI of the project funded by the Croatian Science Foundation “Dissecting the mechanisms of therapy resistance in BRAF-mutant colon cancer using an integrated –omics approach” (2019 – 2023) and the PI of the University of Rijeka research grant “Molecular features associated with BRAFV600E-mutated versus wild type BRAF colorectal cancer” (2019-2022). She is also the PI of the project No. 3238 - EPIC-XS 012: “Proteomic analysis of acquired resistance to vemurafenib in BRAF V600E–mutant colon cancer cells” (2019 - 2022) in collaboration with the Functional Genomics Center Zurich in Switzerland.
A highly accomplished Computational Biologist and Bioinformatician with over 19 years of research expertise. My professional focus is on One Health bioinformatics, using pathogen transcriptomics and genomic surveillance to investigate and control infectious threats and antimicrobial resistance. My career has been marked by a strong track record of developing impactful tools and pipelines, including the Dlact antimicrobial resistance gene database and the Gen2Epi computational pipeline. Currently, as a Bioinformatician and Data Manager at the Vaccine and Infectious Disease Organization (VIDO), I apply my skills to analyze large-scale transcriptomics data and elucidate host-pathogen interactions in both human and animal populations
Dr. Srinivas Sistla is Director of Laboratories within the Microbiology and Immunology Department at State University of New York (SUNY) Stony Brook. He is a trained Biophysics and Drug Discovery Scientist, with experience working for industry and academia.
Dr. Sistla obtained his PhD in 2008 (Biotechnology and Biophysics) and is interested in the following fields of research; Bioactive Peptides, Biochemistry, Biophysics, Medical Biochemistry and Metabolomics, and Surface Plasmon Resonance.
TU Braunschweig & Uni Glasgow. Metagen Gesellschaft für Genomforschung mbH.
Max Planck Institute for Molecular Genetics. Altana Pharma AG. And currently Merck Healthcare KGaA
My speciality areas are Computational Biology, Systems Biology, Oncogenomics, Drug Target Identification, Biomarker Research.
Dr. Ranjit Vijayan obtained his PhD in Life Sciences Interface/Biochemistry from the University of Oxford, UK, and his DipGrad in Management from the London School of Economics & Political Science, University of London, UK. In 2004 Dr Vijayan obtained his MSc in Computer Science from the University of Wales, Aberystwyth, UK, and prior to this his BEng in Electrical & Electronic Engineering, Nanyang Technological University, Singapore.
Dr. Vijayan's research interests include; molecular dynamics simulations of biological macromolecules, protein structure modeling, structure based drug discovery, genomics & transcriptomics, pharmacogenomics and high-performance computing.